Gastric cancer clinical trials

Explore recruiting gastric cancer clinical trials.

Recruiting gastric cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastric cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PERISCOPE-2

Sweden, Finland, Denmark, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination with Trastuzumab and Chemotherapy (XELOX) versus Trastuzumab and Chemotherapy (XELOX) with or without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer

Poland, Romania, Germany, Spain, Italy, Greece +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Local and systemic immune modulation by Rilvegostomig (AZD2936) in the treatment of advanced gastric cancer (RILVE Project)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Gastric Cancer

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Preoperative intravenous iron therapy in patients with gastric cancer

Finland

Therapeutic use (Phase IV) EU CTIS Study details

The PRESTO Trial - Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early stage, cT1 and cT2N0, esophageal adenocarcinoma with indication for radical surgery: A prospective, multicenter study of the FLOT-AIO Gastric Cancer Group

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Gastric cancer trials by city

Gastric cancer in Toronto Gastric cancer in Vancouver Gastric cancer in Montreal Gastric cancer in Calgary Gastric cancer in Edmonton Gastric cancer in Ottawa Gastric cancer in Winnipeg Gastric cancer in Quebec City Gastric cancer in Hamilton Gastric cancer in Kitchener Gastric cancer in London Gastric cancer in Halifax Gastric cancer in New York Gastric cancer in Los Angeles Gastric cancer in Chicago Gastric cancer in Houston

Other conditions

Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Glioblastoma Head and neck cancer Cervical cancer Endometrial cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C COVID-19 Influenza RSV Sickle cell disease Anemia